missing translation for 'onlineSavingsMsg'
Få mere at vide
Få mere at vide
STEMCELL Technologies Imatinib (Mesylate)
Beskrivelse
- Imatinib mesylate is a first generation tyrosine kinase inhibitor that selectively targets certain tyrosine kinases, including ABL, platelet-derived growth factor receptor (PDGFR), and KIT (Druker, 2008; Müller)
- Inhibits proliferation of primary cultured human mesenchymal stem cells, and promotes adipogenic over osteogenic differentiation (Fierro et al.)
- Induces osteoblast differentiation in cultured osteoblastic cells, and reduces osteoclastogenesis in mouse bone marrow cultures (O'Sullivan et al.)
- In CML, Imatinib inhibits the oncoprotein BCR-ABL, the product of the Philadelphia chromosome gene fusion (Carroll et al.; Druker et al.), 1996)
- Inhibits autonomous erythropoiesis in peripheral blood mononuclear cells isolated from patients with polycythemia vera (Oehler et al.)
Tekniske data
Tekniske data
| CAS | 220127-57-1 |
| Synonym | CGP57148B; Gleevec; Glivec; STI-571 |
| Mængde | 25 mg |
| Molekylær formel | C29H31N7O · CH4SO3 |
| Renhed | ≥98% |
Produkttitel
Ved at klikke på Send, anerkender du, at du kan blive kontaktet af Fisher Scientific med hensyn til den feedback, du har givet i denne formular. Vi deler ikke dine oplysninger til andre formål. Alle angivne kontaktoplysninger skal også vedligeholdes i overensstemmelse med vores Privatlivspolitik.
Ser du en mulighed for forbedring?